LobbyingAMC Pharma lobbying by quarter
AMC Pharma's latest lobbying report covers Q1 2025, at under $5,000. Its first report covers Q3 2023; the issues it reports most are Budget/Appropriations and Health Issues.
AMC Pharma
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q3 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2023 | $30K | 1 |
| Q4 2023 | $60K | 1 |
| Q1 2024 | $60K | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Budget and appropriations$75K · 3 reports
- Health issues$75K · 3 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES3 reports
- SENATE3 reports
Firms it paid
| Firm | ||
|---|---|---|
| Chamber Hill Strategies | $150K | 7 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| BERNARD ROTHSCHILD | Members Outreach Director, House Administration Committee; Chief of Staff, Rep. Blake Farenthold (TX-27); Legislative Assistant, Rep. Bill Flores (TX-17); Legislative Assistant, Rep. Michele Bachman (MN-06) | Q1 2024 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 25/04/12for Q1 2025 | Chamber Hill Strategies | Under $5,000 |
| 25/01/19for Q4 2024 | Chamber Hill Strategies | Under $5,000 |
| 24/10/14for Q3 2024 | Chamber Hill Strategies | Under $5,000 |
| 24/07/20for Q2 2024 | Chamber Hill Strategies | Under $5,000 |
| 24/06/13for Q1 2024 | Chamber Hill Strategies | $60K |
| 24/01/19for Q4 2023 | Chamber Hill Strategies | $60K |
| 23/10/20for Q3 2023 | Chamber Hill Strategies | $30K |
| 23/09/30for Q3 2023 | Chamber Hill Strategies | Under $5,000 |